
Posted on :
31
Mar
2025
A guideline for the reporting of pharmacovigilance disproportionality studies: co-leading the elaboration of READUS-PV
New projectIn 2024, the AHeaD team made a significant contribution to pharmacovigilance research by co-developing the READUS-PV guide. This international initiative, co-directed by Professor Francesco Salvo, was launched in response to the need for standardised reporting in disproportionality analyses, which are essential for detecting drug safety signals […]
